14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.450 $0.793 Monday, 22nd Apr 2024 BCLI stock ended at $0.540. This is 1.52% more than the trading day before Friday, 19th Apr 2024. During the day the stock fluctuated 12.48% from a day low at $0.518 to a day high of $0.582.
90 days $0.270 $0.793
52 weeks $0.135 $3.35

Historical Brainstorm Cell Therapeutics Inc. prices

Date Open High Low Close Volume
Jan 03, 2024 $0.278 $0.289 $0.274 $0.279 695 379
Jan 02, 2024 $0.266 $0.300 $0.260 $0.285 1 580 778
Dec 29, 2023 $0.268 $0.278 $0.260 $0.273 1 526 758
Dec 28, 2023 $0.265 $0.280 $0.250 $0.264 2 785 172
Dec 27, 2023 $0.217 $0.286 $0.205 $0.286 6 637 890
Dec 26, 2023 $0.242 $0.250 $0.203 $0.230 23 224 430
Dec 22, 2023 $0.193 $0.204 $0.193 $0.198 517 201
Dec 21, 2023 $0.190 $0.197 $0.190 $0.193 949 642
Dec 20, 2023 $0.200 $0.208 $0.190 $0.194 980 884
Dec 19, 2023 $0.214 $0.222 $0.200 $0.203 1 529 302
Dec 18, 2023 $0.230 $0.245 $0.211 $0.214 839 288
Dec 15, 2023 $0.210 $0.240 $0.205 $0.235 1 356 007
Dec 14, 2023 $0.210 $0.220 $0.185 $0.220 1 708 961
Dec 13, 2023 $0.173 $0.210 $0.170 $0.208 2 539 656
Dec 12, 2023 $0.180 $0.188 $0.165 $0.174 1 693 963
Dec 11, 2023 $0.198 $0.199 $0.173 $0.176 2 687 594
Dec 08, 2023 $0.222 $0.225 $0.199 $0.200 3 068 409
Dec 07, 2023 $0.260 $0.271 $0.220 $0.222 5 914 953
Dec 06, 2023 $0.310 $0.310 $0.230 $0.297 7 245 990
Dec 05, 2023 $0.440 $0.449 $0.300 $0.305 12 413 255
Dec 04, 2023 $0.262 $0.410 $0.260 $0.400 9 504 830
Dec 01, 2023 $0.270 $0.281 $0.240 $0.260 3 759 234
Nov 30, 2023 $0.230 $0.293 $0.224 $0.279 8 307 056
Nov 29, 2023 $0.218 $0.235 $0.205 $0.220 2 799 647
Nov 28, 2023 $0.240 $0.240 $0.215 $0.220 1 942 978
Click to get the best stock tips daily for free!

About Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics. Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative ... BCLI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT